About Gena Pharmaceuticals Limited
Data last updated:
Gena Pharmaceuticals Limited is a public limited company based in Kolkata, West Bengal, India. The company is currently under liquidation, meaning its assets are being sold to settle outstanding debts. It may not have the legal capacity to fulfil new contracts. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 May 2004.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24239WB2004PLC098504. Its GSTIN is 19AACCG2449Q1Z1 (West Bengal).
The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹2.87 Cr. It is led by directors including Vijaykumar Kanoria and Suresh Kumar Sharma.
Its last annual general meeting (AGM) was held on 28 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at 7/2/1 Thakurpukur (N/W) Road P.S Barasat, Kolkata, West Bengal, India – 700128.
As per the financials filed for FY 2020, the company reported a revenue of ₹7.07 Cr, a decline of 30% compared to the previous year. For the same year it recorded a net loss of ₹25.61 Lakh (net margin -3.6%) and EBITDA of ₹34.6 Lakh (EBITDA margin 4.9%). Revenue has declined at a compounded annual rate (CAGR) of 31% over three years and 16% over five years.
The company has about 32 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹32.29 Cr and satisfied charges of ₹11.54 Cr on record. Court records list 46 cases involving the company, including 22 filed by the company and 23 filed against it; 4 cases are pending.
The last known website on record is ipgenapharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address7/2/1 Thakurpukur (N/W) Road P.S Barasat, Kolkata, West Bengal, India – 700128
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Gena Pharmaceuticals Limited
The main business activity of Gena Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Gena Pharmaceuticals Limited FY 2020 filings available
Gena Pharmaceuticals Limited reported revenue of ₹7.07 Cr (down 30% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR) of Gena Pharmaceuticals Limited
Revenue has declined at a compounded annual rate (CAGR) of 16% over five years, including a 30% fall in the latest year. EBITDA fell 13% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Gena Pharmaceuticals Limited
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹7.07 Cr | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹34.6 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹25.61 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Gena Pharmaceuticals Limited
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -3.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Gena Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Gena Pharmaceuticals Limited
Gena Pharmaceuticals Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Startell Bioceuticals Private Limited | ₹7.08 Cr (FY 2025) | •••• | •••• | 30.0% | •••• | Majiwada, Maharashtra, India |
| Nephurocare Pharma Private Limited | ₹7.08 Cr (FY 2025) | •••• | •••• | 17.0% | •••• | Ahmedabad, Gujarat, India |
| Lyka Healthcare Limited | ₹7.07 Cr (FY 2020) | •••• | •••• | -32.0% | •••• | Bhiwandi, Maharashtra, India |
| Acumen Pharmaceuticals Private Limited | ₹7.07 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | Madurai, Tamil Nadu, India |
| Pramukh Swami Pharma Limited | ₹7.07 Cr (FY 2025) | •••• | •••• | 27.0% | •••• | Gandhinagar, Gujarat, India |
| Gena Pharmaceuticals Limited this company | ₹7.07 Cr (FY 2020) | •••• | •••• | -30.0% | •••• | Kolkata, West Bengal, India |
| Winsome Medicare Private Limited | ₹7.06 Cr (FY 2025) | •••• | •••• | 4.0% | •••• | Gurugram, Haryana, India |
| Medvik Pharmaceuticals Private Limited | ₹7.05 Cr (FY 2025) | •••• | •••• | 78.0% | •••• | Delhi, India |
| Vivex Pharmaceuticals Private Limited | ₹7.05 Cr (FY 2024) | •••• | •••• | 51.0% | •••• | Mohali, Punjab, India |
| Pinnacle Therapeutics Private Limited | ₹7.05 Cr (FY 2025) | •••• | •••• | 44.0% | •••• | Ahmedabad, Gujarat, India |
| Kinesis Pharmaceuticals Private Limited | ₹7.04 Cr (FY 2025) | •••• | •••• | -9.0% | •••• | Chennai, Tamil Nadu, India |
Peers are the five companies nearest above and the five nearest below Gena Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Gena Pharmaceuticals Limited
Gena Pharmaceuticals Limited is audited by R.LAHIRI & CO for the financial year 2020.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| R.LAHIRI & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Gena Pharmaceuticals Limited
Gena Pharmaceuticals has 6 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Suresh Kumar Sharma Also directs: Metsil Exports . Ltd. | Additional Director | 16 Dec 2022 | 3 Years 10 Months | As last reported |
| Arabind Kumar Mishra | Additional Director | 30 Sep 2011 | 15 Years 0 Months | As last reported |
| Vijaykumar Kanoria Also directs: Gena Marketing Private Limited | Director | 23 May 2012 | 14 Years 4 Months | As last reported |
| Abhishek Kumar Shukla Also directs: Gena Marketing Private Limited, Pincon Lifestyle Limited, Vinda Vashni Oils Private Limited and 5 more | Additional Director | 04 Jun 2019 | 7 Years 4 Months | As last reported |
| Santosh Kumar Sharma Also directs: Metsil Exports . Ltd. | Additional Director | 16 Dec 2022 | 3 Years 10 Months | As last reported |
| Rintu Bhattacharjee Also directs: Metsil Exports . Ltd., Bhaskar Industrial Developments Limited, Amritvani Exim Pvt Ltd and 3 more | Additional Director | 16 Dec 2022 | 3 Years 10 Months | As last reported |
Ownership and Shareholding of Gena Pharmaceuticals Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Gena Pharmaceuticals Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Oct 2008 | Edelweiss Asset Reconstruction Company Limited | ₹12.66 Cr | Open |
| 28 Aug 2008 | Edelweiss Asset Reconstruction Company Limited | ₹12.66 Cr | Open |
| 03 Aug 2007 | Andhra Bank | ₹6.98 Cr | Open |
| 26 Oct 2004 | United Bank of India | ₹11.54 Cr | Satisfied |
Total charge records: 4 View all charges
Legal Cases of Gena Pharmaceuticals Limited
Gena Pharmaceuticals Limited has 46 court cases on record: 22 filed by Gena Pharmaceuticals, 23 filed against it, 1 where it is another party. 4 cases are pending and 42 are disposed. Status as checked between 28 Sep 2026 and 05 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 23 | 19 | 2 |
| High courts | 22 | 4 | 2 |
| Supreme Court | 1 | 0 | 0 |
Cases on record (5 of 46)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Calcutta High Court | Civil suit | Filed by the company against Idbi Bank Limited | Pending |
| Bombay High Court | Court case (APEAL) | Filed against the company by Titan Laboratories Private Limited | Disposed |
| Calcutta High Court | Company petition | Filed by the company against Edelweiss Asset Reconstruction Company Limited | Disposed |
| District court, Calcutta, West Bengal | Civil suit | Filed against the company by Fairplan Vincom Pvt Ltd | Disposed |
| District court, Calcutta, West Bengal | Civil suit | Filed against the company by Zeolite India Pvt Ltd | Disposed |
Full case history
All 46 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Gena Pharmaceuticals Limited
Gena Pharmaceuticals Limited has a workforce of 32 employees as of Jan 15, 2025.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Gena Pharmaceuticals Limited
Gena Pharmaceuticals has one previous CIN (Corporate Identification Number): U24239WB2004PTC098504. The current CIN is U24239WB2004PLC098504, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239WB2004PLC098504 | Current |
| U24239WB2004PTC098504 | Previous |
Recent Activity on Gena Pharmaceuticals Limited
Gena Pharmaceuticals Limited has 11 board changes on record since 2011: 6 appointments and 5 cessations. The latest: Rintu Bhattacharjee was appointed as Additional Director on 16 Dec 2022.
11 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Gena Pharmaceuticals Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Gena Pharmaceuticals Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Gena Pharmaceuticals Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Gena Pharmaceuticals Limited
Gena Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AACCG2449Q1Z1 | West Bengal | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Gena Pharmaceuticals Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gena Pharmaceuticals Limited
Gena Pharmaceuticals is currently "Under Liquidation" as per MCA records. The company's assets are being sold to settle outstanding debts owed to creditors. A company under liquidation may not have the legal capacity to fulfil new contracts, and creditors are prioritised in the distribution of proceeds. This is a high-risk status - caution is strongly advised.
Gena Pharmaceuticals is a company under liquidation, formerly operating as a public limited company based in Kolkata, West Bengal, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 11 May 2004 and is registered under CIN U24239WB2004PLC098504. Caution is advised - the company may not have the legal capacity to fulfil new agreements.
Gena Pharmaceuticals reported revenue of ₹7.07 Cr for FY 2020 (down 30% YoY).
Gena Pharmaceuticals has 6 current directors:
- Suresh Kumar Sharma - Additional Director
- Arabind Kumar Mishra - Additional Director
- Vijaykumar Kanoria - Director
- Abhishek Kumar Shukla - Additional Director
- Santosh Kumar Sharma - Additional Director
- Rintu Bhattacharjee - Additional Director
Gena Pharmaceuticals reported a net loss of ₹25.61 Lakh (net margin -3.6%) and EBITDA of ₹34.6 Lakh (EBITDA margin 4.9%) for FY 2020, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Gena Pharmaceuticals is -31% over three years and -16% over five years. In the latest year (FY 2020) revenue fell 30%. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of Gena Pharmaceuticals is U24239WB2004PLC098504. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Gena Pharmaceuticals has open charges of ₹32.29 Cr and satisfied charges of ₹11.54 Cr as per latest MCA filings.
Gena Pharmaceuticals has 46 court cases on record: 22 filed by the company and 23 filed against it. 4 are pending. Most are in the district courts.
Gena Pharmaceuticals was incorporated on 11 May 2004. It is registered with the Registrar of Companies, Kolkata.
The peers of Gena Pharmaceuticals by revenue are Startell Bioceuticals Private Limited, Nephurocare Pharma Private Limited, Lyka Healthcare Limited, Acumen Pharmaceuticals Private Limited, Pramukh Swami Pharma Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).